Literature DB >> 16736739

Brain & chiasmal herniations into sella after medical treatment of prolactinoma.

M H Bangash1, D B Clarke, R O Holness.   

Abstract

BACKGROUND: Dopamine agonists are widely used in the treatment of pituitary prolactinomas. We report a case of inferior mesial frontal lobe (gyrus rectus) and chiasmal herniations into an enlarged sella following successful medical treatment of a pituitary macroadenoma.
METHOD: A 71-year-old healthy man presented to medical attention with visual complaints. On examination, he was found to have bitemporal hemianopsia. Endocrine evaluation revealed an elevated prolactin level. He was treated medically with a dopamine agonist (bromocriptine).
RESULTS: Evaluation after one year of medical treatment revealed stabilization of the patient's vision, with a significant bitemporal field loss. Serum prolactin levels normalized (5.16 ng/ml). The MRI of the sella showed almost complete disappearance of the tumor, resulting in right mesial frontal lobe herniation inferiorly into an enlarged sella with associated chiasmal deformation.
CONCLUSIONS: We report a case where successful medical treatment of a large pituitary prolactinoma has resulted in inferior frontal lobe and chiasmal herniatons into an enlarged sella.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736739     DOI: 10.1017/s0317167100005060

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  3 in total

1.  Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.

Authors:  Dinesh Kumar Dhanwal; Ashok Kumar Sharma
Journal:  Pituitary       Date:  2009-04-19       Impact factor: 4.107

2.  Brain and Optic Chiasm Herniation into Sella after Pituitary Tumor Apoplexy.

Authors:  Maria M Pineyro; Patricia Furtenbach; Ramiro Lima; Saul Wajskopf; Nicolas Sgarbi; Raul Pisabarro
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-07       Impact factor: 5.555

3.  Empty Sella Syndrome as a Window Into the Neuroprotective Effects of Prolactin.

Authors:  David A Paul; Emma Strawderman; Alejandra Rodriguez; Ricky Hoang; Colleen L Schneider; Sam Haber; Benjamin L Chernoff; Ismat Shafiq; Zoë R Williams; G Edward Vates; Bradford Z Mahon
Journal:  Front Med (Lausanne)       Date:  2021-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.